SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15878386
Source:
http://linkedlifedata.com/resource/pubmed/id/15878386
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008902
,
umls-concept:C0030705
,
umls-concept:C0036525
,
umls-concept:C0069717
,
umls-concept:C0123931
,
umls-concept:C0687133
,
umls-concept:C0750502
,
umls-concept:C1522484
,
umls-concept:C1527249
,
umls-concept:C2745955
pubmed:issue
3
pubmed:dateCreated
2005-5-9
pubmed:abstractText
Pharmacokinetic and pharmacodynamic drug interactions with cytotoxic drugs may significantly influence the efficacy and toxicity of chemotherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
,
http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0149-2918
pubmed:author
pubmed-author:BrouwersJacobus R B JJR
,
pubmed-author:CoenenJules L L MJL
,
pubmed-author:IdzingaFroukje S FFS
,
pubmed-author:JansmanFrank G AFG
,
pubmed-author:SleijferDirk ThDT
,
pubmed-author:SmitWillem MWM
,
pubmed-author:de GraafJacques CJC
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
327-35
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15878386-Adolescent
,
pubmed-meshheading:15878386-Adult
,
pubmed-meshheading:15878386-Aged
,
pubmed-meshheading:15878386-Antineoplastic Agents
,
pubmed-meshheading:15878386-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:15878386-Camptothecin
,
pubmed-meshheading:15878386-Colorectal Neoplasms
,
pubmed-meshheading:15878386-Drug Interactions
,
pubmed-meshheading:15878386-Female
,
pubmed-meshheading:15878386-Humans
,
pubmed-meshheading:15878386-Male
,
pubmed-meshheading:15878386-Middle Aged
,
pubmed-meshheading:15878386-Neoplasm Metastasis
,
pubmed-meshheading:15878386-Organoplatinum Compounds
pubmed:year
2005
pubmed:articleTitle
Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer.
pubmed:affiliation
Department of Clinical Pharmacy, Isala Klinieken, Zwolle, the Netherlands. f.g.a.jansman@isala.nl
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study